10/03/2023Immunome and Morphimmune Announce Successful Completion of Merger with $125 Million PIPE to Develop Novel Targeted Cancer Therapies
06/29/2023Immunome and Morphimmune Announce Definitive Merger Agreement and Simultaneous Private Placement Investment of $125 Million to Develop Targeted Cancer Therapies
05/23/2023Immunome Publishes Preclinical Research Demonstrating that Inhibition of IL-38 Using an Antibody Leads to Anti-Tumor Activity
02/08/2023Immunome Announces Formation of Antibody-Drug Conjugate and T Cell Redirection Advisory Board
01/06/2023AbbVie and Immunome Announce Strategic Collaboration to Discover Multiple Novel Oncology Targets
